TAN-67, a δ1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels

American Journal of Physiology

Volumn 274, Issue 3 PART 2, 1998, Pages

  Schultz, J O E L J ^a   Hsu, Anna K ^a   Nagase, Hiroshi ^a   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Glibenclamide; Isch mie preconditioning; Pertussis toxin

Indexed keywords

EID: 33750881648     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Bugge, E., J. Munch-Ellingsen, and K. Ytrehus. Reduced infarct size in the rabbit heart in vivo by ethylisopropylamiloride. A role for Na+/H+ exchange. Basic Res. Cardiol. 91: 203-209,1996.
2. Chen, Y., A. Mesick, J. Liu, A. Hurley, and L. Yu. Molecular cloning and functional expression of a fi opioid receptor from rat brain. Mol. Pharmacol. 44:8-12,1993.
3. + channel. J. Biol. Chem. 269: 7839-7842,1994.
4. Chien, S., P. R. Oeltgen, J. N. Diana, and R. K. Salley. Extension of tissue survival time in multiorgan block preparation with a delta opioid DADLE ([D-AIa2,D-Lcu5]-enkephalin). J. Thorac. Cardiovasc. Surg, 107: 964-967,1994.
5. Childers, S. R. Opioid receptor-coupled second messenger systems. Life Sci. 48:1991-2003,1991.
6. Clarke, G. D., and G. M. Dondio. Recent advances in the development of a non-peptide 8 opioid analgesic. Pharmacol. Rev. Commun. 9:49-60,1997.
7. Cox, B. M. Opioid receptor-G protein interactions: acute and chronic effects of opioids. In: Handbook of Experimental Pharmacology: Opioids I, edited by A. Herz. New York: Springer-Verlag, 1993, p. 145-188.
8. Donnelly, T. J., R. E. Sievers, F. L. J. Vissern, W. J. Welch, and C. L. Wolfe. Heat shock protein induction in rat hearts: a role for improved myocardial salvage after ischemia and reperfusion? Circulation 85: 769-778,1992.
9. Ela, C., J. Barg, Z. Vogel, Y. Hasin, and Y. Eilam. Distinct components of morphine effects on cardiac myocytes are mediated by the K and 8 opioid receptors. J. Mol. Cell. Cardiol. 29: 711-720,1997.
10. Ela, C., Y. Hasin, and Y. Eilam. Opioid effects on contractility, Ca2Mransients and intracellular pH in cultured cardiac myocytes. J. Mol. Cell. Cardiol. 26: 599-613,1993.
11. Endoh, M., M. Maruyama, and T. lijima. Attenuation of muscarinic cholinergic inhibition by islet-activating protein in the heart. Am. J. Physiol. 249 (Heart Circ. Physiol. 18): H309H320,1985.
12. Evans, C. J., D. E. Keith, Jr., H. Morrison, K. Magendzo, and R. H. Edwards. Cloning of a delta opioid receptor by functional expression. Science 258:1952-1955,1992.
13. Fleming, J. W., P. L. Wisler, and A. M. Watanabe. Signal transduction by G proteins in cardiac tissues. Circulation 85: 420-433,1992.
14. Gross, G. J., and J. A. Auchampach. Blockade of the ATPsensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res. 70:223-233,1992.
15. + channel. Biochem. Biophys. Res. Commun. 208:302-308,1995.
16. Imagawa, J.-L, G. F. Baxter, and D. M. Yellon. Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischémie preconditioning in the rabbit. J. Mol. Cell. Cardiol. 29:1885-1893,1997.
17. + channel. J. Gen. Physiol. 99:961-983,1992.
18. Kamei, J., A. Saitoh, M. Ohsawa, T. Suzuki, M. Misawa, H. Nagase, and Y. Kasuya. Antinociceptive effects of the selective non-peptidic 8-opioid receptor agonist TAN-67 in diabetic mice. Eur. J. Pharmacol. 276:131-135,1995.
19. Kieffer, B. L., K. Befort, C. Gaveriaux-Ruff, and C. G. Hirth. The delta opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89:12048-12052,1992.
20. Kirsch, G. E., J. Codina, L. Birnbaumer, and A. M. Brown. Coupling of ATP-sensitive potassium channels to AI receptors by G proteins in rat ventricular myocytes. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H820-H826,1990.
21. Klein, H. H., S. Puschmann, J. Schaper, and W. Schaper. The mechanism of the tetrazolium reaction in identifying myocardial infarction. Virchows Arch. 393:287-297,1981.
22. Knapp, R. J., R. Landsman, S. Waite, E. Malatynska, E. Varga, W. Haq, V. J. Hruby, W. R. Roeske, H. Nagase, and H. I. Yamamura. Properties of TAN-67, a nonpeptidic 6-opioid receptor agonist, at cloned human 8- and u-opioid receptors. Eur. J. Pharmacol. 291:129-134,1995.
23. Krumins, S. A., A. I. Faden, and G. Feurestein. Opiate binding in rat hearts: modulation of binding after hemorrhagic shock. Biochem. Biophys. Res. Commun. 127: 120-128,1985.
24. Kurachi, Y. G-protein control of cardiac potassium channels. Trends Cardiovasc. Med. 4:64-69,1994.
25. + channels. Prog. Neurobiol. 39:229-246,1992.
26. Lasley, R. D., and R. M. Mentzer. Pertussis toxin blocks adenosine AI receptor mediated protection of the ischémie rat heart. J. Mol. Cell. Cardiol. 25:815-821,1993.
27. Law, P. Y., T. M. McGinn, K. M. Campbell, L. E. Erickson, and H. H. Loh. Agonist activation of 8-opioid receptor but not μ-opioid receptor potentiates fetal calf serum or tyrosine kinase receptor-mediated cell proliferation in a cell-line-specific manner. Mol. Pharmacol. 51:152-160,1997.
28. Lou, L.-G., and G. Pei. Modulation of protein kinase C and cAMP-dependent protein kinase by S-opioid. Biochem. Biophys. Res. Commun. 236:626-629,1997.
29. Li, Y., and R. A. Kloner. Does protein kinase C play a role in ischémie preconditioning in rat hearts? Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H426-H431,1995.
30. Liu, G. S., J. Thornton, D. M. Van Winkle, A. W. H. Stanley, R. A. Olsson, and J. M. Downey. Protection against infarction afforded by preconditioning is mediated by AI adenosine receptors in rabbit heart. Circulation 84:350-356,1991.
31. Liu, Y., and J. M. Downey. Ischémie preconditioning protects against infarction in rat heart. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1107-H1112,1992.
32. Maulik, N., M. Watanabe, Y.-L. Zu, C.-K. Huang, G. A. Cordis, J. A. Schley, and D. K. Das. Ischémie preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEES Lett. 396:233-237,1996.
33. Mayfield, K. P., and L. G. D'Alecy. Delta-1 opioid receptor dependence of acute hypoxic adaptation. J. Pharmacol. Exp. Ther. 268: 74-77,1994.
34. Mayfield, K. P., and L. G. D'Alecy. Delta-1 opioid agonist acutely increases hypoxic tolerance. J. Pharmacol. Exp. Ther. 268:683-688,1994.
35. McKenzie, F. R., and G. Milligan. 8-Opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein G;2. Biochem. J. 267: 391398,1990.
36. Minami, M., T. Toya,Y. Katao, K. Maekawa, S. Nakamura, T. Onogi, S. Kaneko, and M. Satoh. Cloning and expression of a cDNAfor the rat K-opioid receptor. FEBS Lett. 329:291-295,1993.
37. Nagase, H., H. Wakita, K. Kawai, T. Endoh, H. Matsuura, C. Tanaka, and Y. Takezawa. Syntheses of non-peptidic delta opioid agonists and their structure-activity relationships (Abstract). Jpn. J. Pharmacol. 64:35P, 1994.
38. North, R. A., J. T. Williams, A. Surprenant, and M. J. Christie. // and 8 receptors belong to a family of receptors that are coupled to potassium channels. Proc. Natl. Acad. Sci. USA 84:5487-5491,1987.
39. Pepe, S., R.-P. Xiao, C. Hohl, R. Altschuld, and E. G. Lakatta. "Cross talk" between opioid peptide and adrenergic receptor signaling in isolated rat heart. Circulation 95: 2122-2129,1997.
40. Piper, H. M., C. Baiser, Y. V. Ladilov, M. Schafer, B. Siegmund, M. Ruiz-Meana, and D. Garcia-Dörado. The role of Na+/H+ exchange in ischemia-reperfusion. Basic Res. Cardiol. 91:191-202,1996.
41. Portoghese, P. S., M. Sultana, H. Nagase, and A. E. Takemori. A highly selective 8j-opioid receptor antagonist: 7benzylidenenaltrexone. Eur. J. Pharmacol. 218:195-196,1992.
42. Qian, Y. Z., J. E. Levasseur, K.-I. Yoshida, and R. C. Kukreja. KATP channel in rat heart: blockade of ischémie and acetylcholinemediated preconditioning by glibenclamide. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H23-H28,1996.
43. Richard, V., R. Blanc, N. Kaeffer, C. Tron, and C. Thuillez. Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide. Br. J. Pharmacol. 115:1532-1538,1995.
44. Rohmann, S., H. Weygandt, and K.-O. Minck. Preischaemic as well as postischaemic application of a Na+/H+ exchange inhibitor reduces infarct size in pigs. Cardiovasc. Res. 30: 945-951,1995.
45. Schultz, J. J., A. K. Hsu, and G. J. Gross. Morphine mimics the cardioprotective effect of ischémie preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ. Res. 78:1100-1104,1996.
46. Schultz, J. J., A. K. Hsu, and G. J. Gross. Ischémie preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart. J. Mol. Cell. Cardiol. 29: 1355-1362, 1997.
47. Schultz, J. J., A, K. Hsu, and G. J. Gross. Ischémie preconditioning and morphine-induced cardioprotection involve the delta (B)-opioid receptor in the intact rat heart. J. Mol. Cell. Cardiol. 29: 2187-2195,1997.
48. Schultz, J. J., A. K. Hsu, H. Nagase, and G. J. Gross. Ischémie preconditioning (IPC) in the intact rat heart is mediated by delta (81), but not mu (ft) or kappa (K) opioid receptors (Abstract). J. Mol. Cell. Cardiol. 29:A200,1997.
49. Schultz, J. J., Y. Z. Qian, G. J. Gross, and R. C. Kukreja. The ischemia-selective KATP channel antagonist, 5-hydroxydecanoate, blocks ischémie preconditioning in the rat heart. J. Mol. Cell. Cardiol. 29:1055-1060,1997.
50. Schultz, J. J., E. Rose, Z. Yao, and G. J. Gross. Evidence for involvement of opioid receptors in ischémie preconditioning in rat hearts. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H2157H2161,1995.
51. Schultz, J. J., Z. Yao, I. Cavero, and G. J. Gross. Glibenclamide abolishes ischémie preconditioning in a time-dependent manner in the rat heart. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H2607-H2615,1997.
52. Sofuoglu, M., P. S. Portoghese, and A. E. Takemori. 7Benzylidenenaltrexone (BNTX): a selective Si opioid receptor antagonist in the mouse spinal cord. Life Sci. 52: 769-775,1993.
53. Speechly-Dick, M. E., M. M. Mocanu, and D. M. Yellon. Protein kinase C: its role in ischémie preconditioning in the rat. Circ. Res. 75:586-590,1994.
54. Thornton, J. D., G. S. Liu, and J. M. Downey. Pretreatment with pertussis toxin blocks the protective effects of preconditioning: evidence for G-protein mechanism. J. Mol. Cell. Cardiol. 25: 311-320,1993.
55. Ventura, C., L. Bastagli, P. Bernard!, C. M. Caldarera, and C. Guarnieri. Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol. Biochim. Biophys. Acta 987: 69-74,1989.
56. Ventura, C., H. Spurgeon, E. G. Lakatta, C. Guarnieri, and M. C. Capogrossi. K and 5 opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons. Circ. Res. 70:66-81,1992.
57. Wild, K. D., T. Vanderah, H. I. Mosberg, and F. Porreca. Opioid 5 receptor subtypes are associated with different potassium channels. Ear. J. Pharmacol. 193:135-136,1991.
58. Williams, J. T., T. M. Egan, and R. A. North. Enkephalin opens potassium channels on mammalian central neurons. Nature 299: 74-77,1982.
59. Wittert, G., P. Hope, and D. Pyle. Tissue distribution of opioid receptor gene expression in the rat. Biochem. Biophys. Res. Commun. 218:877-881,1996.
60. Xiao, R.-P., S. Pepe, H. A. Spurgeon, M. C. Capogrossi, and E. G. Lakatta. Opioid peptide receptor stimulation reverses β-adrenergic effects in rat heart cells. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H797-H805,1997.
61. Yao, Z., and G. J. Gross. Acetylcholine mimics ischémie preconditioning via a glibenclamide-sensitive mechanism in dogs. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H2221-H2225,1993.
62. Yao, Z., and G. J. Gross. Role of nitric oxide, muscarinic receptors, and the ATP-sensitive potassium channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ. Res. 73:1193-1201,1993.
63. Yasuda, K., K. Raynor, H. Kong, C. Breder, J. Takeda, T. Reisine, and G. I. Bell. Cloning and function comparison of kappa and delta opioid receptors from mouse brain. Proc. Natl. Acad. Sci. USA 90:6736-6740,1993.
64. Ytrehus, K., E. Bugge, J. Starkopf, and A. K. Jonassen. Mechanisms of endogenous protection against infarction in the rat heart: from oxidative stress to signal transduction? (Abstract). J. Mol. Cell. Cardiol. 29: A14,1997.
65. Ytrehus, K., Y. Liu, and J. M. Downey. Preconditioning protects ischémie rabbit heart by protein kinase C activation. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1145-H1152,1994.
66. Zimlichman, R., D. Gefel, H. Eliahou, Z. Matas, B. Rosen, S. Gass, C. Ela, Y. Eilam, Z. Vogel, and J. Barg. Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats. Circulation 93:1020-1025,1996.